Stocks To Buy Now

Blog


DGE’s 5th PRC Performance Optimization Summit in Philadelphia to Cover all Aspects of Promotional Review

The 5th PRC Performance Optimization Summit by DGE will be held in Philadelphia on April 29-30, 2025. DGE invites industry professionals to discuss compliance and the expertise needed to get the best regulatory results for advertising/promotional material.

The summit is hosted by Dynamic Global Events (“DGE”), a pioneer in organizing B2B events for life science companies. DGE offers the biopharma, healthcare, and medical device industries a robust forum for discussion, education, and collaboration.

Promotional review committees must be well-equipped in a rapidly evolving regulatory environment to stay abreast of the best practices for new technologies and platforms. Teams must listen to all voices and adapt to making necessary changes during the lifecycle of the drug.

The agenda of the PRC Performance Optimization Summit is to identify the biggest challenges and find winning execution strategies. Some of the topics include compliance with new CCN Dual Modality rules, managing review escalations, working with the Better Business Bureau, and grasping how AI impacts promotional review, to name a few. Experts will also conduct panel discussions about the tools to help reduce conflicts among team members.

Over two dozen speakers will share their invaluable insights that attendees can learn and understand to achieve the desired regulatory results. Industry veterans will also interact with the audience and solve their queries.

This important DGE event will focus on analyzing the best technical expertise to achieve regulatory compliance and meet deadlines across all media platforms. Participants looking to expand their network can leverage their reach by engaging with experts across the industry.

To learn more, please visit https://ibn.fm/3cdhG.

From Our Blog

Soligenix Inc. (NASDAQ: SNGX) HyBryte(TM) Paves Way for Breakthrough Treatment for Rare Skin Cancer

May 1, 2025

The development of treatments for rare diseases remains one of the most pressing challenges in modern medicine. Despite significant advancements in healthcare, many rare diseases still have no approved treatments, and patients often face grim prospects. The market for treatments in this space is substantial, as rare diseases collectively affect millions of people worldwide. Among […]

Rotate your device 90° to view site.